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Objective  To identify the relationship between maximum phonation time (MPT) and swallowing function, as well 
as the elements of swallowing, in order to provide a rationale for speech therapy in patients with Parkinsonism 
manifesting dysphagia.
Methods  Thirty patients with Parkinsonism who underwent speech evaluation and videofluoroscopic swallowing 
study (VFSS) were recruited. The MPT, the longest periods of sustained pronunciation of /aa/, was evaluated. 
The VFSS was evaluated using Penetration Aspiration Scale (PAS), National Institutes of Health-Swallowing Safety 
Scale (NIH-SSS), and Videofluoroscopic Dysphagia Scale (VDS). The relationship between dysphagia scales and 
MPT was analyzed using Pearson correlation. The difference in VDS variables between subgroups (Parkinson 
disease or Parkinsonian syndrome, independent or dependent ambulation, and normal or abnormal MPT) and 
the difference in MPT between subgroups based on the VDS variables were analyzed using the independent t-test.
Results  Bolus formation and laryngeal elevation functions were significantly higher in the normal MPT group 
compared with the impaired group. In the VDS variables, patients with intact bolus formation, oral transit time, 
pharyngeal swallow triggering, and laryngeal elevation showed significantly longer MPTs compared with the 
impaired groups. In addition, MPT was significantly correlated with the VDS and modestly correlated with the 
NIH-SSS, but not the PAS, suggesting that phonatory function is related to the oropharyngeal swallowing function, 
but not directly to the aspiration itself.
Conclusion  The correlation between MPT and several swallowing-related elements was identified, indicating an 
interactive correlation between swallowing and phonation. This result justifies voice therapy as a treatment for 
dysphagia in patients with Parkinsonism.
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INTRODUCTION
Parkinson disease (PD) is a complex, progressive, neu-
rodegenerative disorder resulting in a wide range of defi-
cits [1,2]. Speech and swallowing function are impaired, 
even in the early stages, significantly affecting health and 
the quality of life [3].
The cause of dysphagia in patients with PD is not 
clearly understood; however, a dysfunction involving the 
central pattern generator for swallowing in the brainstem 
and degeneration of the substantia nigra are possible 
causes that contribute to damaged non-dopaminergic 
neural networks [4,5]. Such damage leads to oral and 
pharyngeal phase dysfunction, which is characterized by 
abnormal bolus formation, repetitive tongue pumping, 
delayed swallowing reflex, decreased elevation of the hy-
olaryngeal complex, residues in both the vallecular and 
pyriform sinuses, and limited pharyngeal peristalsis [6].
Dysphagia not only affects the nutritional status of 
patients, but also their social interaction, susceptibil-
ity to fatigue, quality of life, and many other aspects. It 
may also lead to aspiration pneumonia, which is a major 
cause of death in patients with PD [1,4,7].
Conventional treatments such as bolus modification, 
postural and airway protective maneuvers, and pharma-
cological interventions, as well as other treatments such 
as expiratory muscle strength training, thermal-tactile 
stimulation, electrical stimulation, logopedic dysphagia 
treatment, and surgical intervention have been used to 
manage dysphagia in patients with PD. However, the 
long-term effects have yet to be verified, while a few stud-
ies have shown short-term benefits [4,8]. 
Since organs related to swallowing and speech are 
structurally and neurologically linked, speech therapy 
has been used to treat dysphagia without any evidence of 
sustained long-term benefits [4,9]. 
This study was conducted in patients with PD and 
Parkinsonian syndrome (PS) to identify the relationship 
between the maximum phonation time (MPT) and swal-
lowing function, as well as the elements of swallowing, 
to provide a rationale for the use of voice therapy for the 
treatment of dysphagia. 
MATERIALS AND METHODS
Subjects
Thirty patients diagnosed with PD or PS, who visited 
the clinic of the Department of Rehabilitation Medicine 
from January 2007 to December 2016 and underwent 
speech evaluation and videofluoroscopic swallowing 
study (VFSS), were included in this study. VFSS and 
speech evaluation were conducted simultaneously on el-
igible and selected patients. Patients with secondary Par-
kinsonism related to drugs, infection, or hydrocephalus 
were excluded. Patients with other neurological deficits 
and medical diseases, such as stroke or severe cardio-
pulmonary disease that may affect dysphagia were also 
excluded. 
Of the 30 patients, 10 manifested PD and 20 had PS. 
The 20 patients with PS included 15 manifesting multiple 
system atrophy, 2 cases of dementia with Lewy body, 
and 1 with corticobasal degeneration. Of the 30 patients, 
the MPT was found normal in 9 and abnormal in 21. 
The baseline characteristics, including ambulatory and 
functional status and dysphagia scale scores, are listed 
in Table 1. This study was approved by the Institutional 
Review Board of Yonsei University Health System (No. 
4-2014-0528). 
Methods
Speech evaluation and VFSS were conducted to com-
pare swallowing and speech. The speech evaluation was 
conducted by speech therapists in the form of one-on-one 
sessions in the treatment units. The MPT was measured 
with the pronunciation of /aa/ as the primary value. The 
MPT represent the maximum time (in seconds) for which 
an individual can sustain a vowel sound when uttered on 
one deep breath at a reasonably comfortable pitch and 
loudness. MPT is used to indirectly evaluate the laryngeal 
function and vocal cord vibration [10,11]. It was widely 
used since it is easier to access than the other parameters 
of evaluation. Compared with other acoustic parameters, 
MPT is relatively easy to evaluate regardless of the pa-
tient’s function or cognition. It can be used in older pa-
tients and patients with Parkinsonism. Furthermore, MPT 
is user-friendly since the patients or the caregivers can 
evaluate the changes themselves. In addition, its relation-
ship with aspiration, which is the most important factor in 
dysphagia, was observed in previous studies [12]. 
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MPT testing requires deep inhalation and a relaxed 
voice without stopping. The normal standard for MPT was 
based on the normal standards for age and sex as recom-
mended by ‘Neurologic Speech-Language Disorders’ [13]. 
VFSS was performed by experienced physiatrists in a 
fluoroscopy/radiography room. The subjects sat later-
ally in a posture that was appropriate for observation 
of the anatomical structure and function. The subjects 
swallowed 5 mL and 15 mL of 12% semisolids followed 
by 5 mL and 15 mL of liquid, in the stated order, which 
were all mixed with barium sulfate solution. The test was 
recorded on video, which was evaluated by two physiat-
rists. The Penetration Aspiration Scale (PAS), National In-
stitutes of Health-Swallowing Safety Scale (NIH-SSS), and 
Videofluoroscopic Dysphagia Scale (VDS) scores were 
evaluated. 
Video fluoroscopic swallowing study analysis 
National Institutes of Health-Swallowing Safety Scale
The NIH-SSS is a numerical scale that quantifies swal-
lowing safety based on the observations derived from the 
VFSS, including food residue, laryngeal penetration, as-
piration response, maximal esophageal entry, and mul-
tiple swallows. Higher scores indicate greater impairment 
[14].
Penetration aspiration scale
The PAS is a numerical scale that quantifies the degree 
of penetration and aspiration observed during VFSS. This 
8-point scale is used to assess the depth of the passage of 
a bolus into the airway and the patient’s response. Higher 
scores indicate greater impairment [15].
Videofluoroscopic dysphagia scale
The VDS for oropharyngeal functional assessment dur-
ing swallowing is based on the following 14 items: lip 
closure, bolus formation, mastication, apraxia, tongue-
to-palate contact, premature bolus loss, oral transit time, 
pharyngeal swallow triggering, vallecular residue, laryn-
geal elevation, pyriform sinus residue, coating of pharyn-
geal wall, pharyngeal transit time, and aspiration [16]. 
The scale has a maximum score of 100. Higher scores 
indicate poor swallowing function. 
Statistical analysis
Data were imported into SPSS version 20.0 (IBM, Ar-
monk, NY, USA) for analysis. Statistical analysis of VDS 
variables across subgroups was performed using an in-
dependent t-test. The differences in MPT between the 
subgroups, which were classified based on the VDS vari-
ables, were compared using the independent t-test. To 
determine the correlation between dysphagia scales and 
MPT, Pearson correlation coefficients were calculated; 
values above 0.6 were considered strong and those rang-
ing between 0.4 and 0.6 were moderate. A p-value <0.05 
was considered statistically significant. 
RESULTS
Baseline demographic and clinical characteristics 
VFSS and speech evaluation were performed in 30 
patients (10 PD and 20 PS). The 30 patients included 16 
males and 14 females. Sixteen patients were ambulatory 
Table 1. Baseline demographic and clinical characteris-
tics of patients
Variable
PD
(n=10)
PS
 (n=20)
Total
(n=30)
Age (yr) 72.1±9.4 67.4±11.6 69.0±11.0
Sex
   Male 5 (16.7) 11 (36.7) 16 (53.3)
   Female 5 (16.7) 9 (30.0) 14 (46.7) 
Ambulation
   Dependent W/C 5 (16.7) 9 (0.3) 14 (46.7)
   Independent W/C 1 (3.3) 3 (10.0) 4 (13.3)
   Standing alone 0 (0) 4 (13.3) 4 (13.3)
   Walking with aid 1 (3.3) 1 (3.3) 2 (6.7)
   ID walking (indoor) 2 (6.7) 1 (3.3) 3 (10.0)
   ID walking (outdoor) 1 (3.3) 2 (6.7) 3 (10.0)
H&Y stage 3.8±1.5 3.8±1.4 3.8±1.4
MBI 26.0±16.4 31.7±21.2 28.8±20.2
FIM 53.4±18.0 53.5±18.9 55.7±14.8
NIH-SSS 3.2±2.8 2.6±2.0 2.8±2.3
PAS 4.0±3.2 4.5±2.9 4.3±2.9
VDS 34.5±24.1 28.5±13.7 30.5±17.7
Values are presented as mean±standard deviation or num-
ber (%). 
PD, Parkinson’s disease; PS, Parkinsonian syndrome; W/
C, wheelchair; ID, independent; H&Y, Hoehn and Yahr; 
MBI, Modified Barthel Index; FIM, Functional Indepen-
dence Measure; NIH-SSS, National Institutes of Health-
Swallowing Safety Scale; PAS, Penetration Aspiration 
Scale; VDS, Videofluoroscopic Dysphagia Scale.
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(with or without device) and 14 were non-ambulatory. 
No statistically significant difference was observed in the 
Hoehn and Yahr (H&Y) stages, Modified Barthel Index, 
and Functional Independence Measures between pa-
tients diagnosed with PD and PS (Table 1). 
Comparison of VDS variables among subgroups 
The patients were divided into the following groups: PD 
or PS, independent or dependent ambulation, and nor-
mal or abnormal MPT. These groups were compared to 
determine differences in their VDS variables. The results 
showed significant differences in bolus formation (0.0±0.0 
vs. 0.7±1.3; p=0.021) and laryngeal elevation (0.0±0.0 vs. 
1.7±3.6; p=0.042) between normal and abnormal MPT 
groups (Table 2).
Comparison of mean MPT in the VDS subgroups 
Among the 30 patients, 22 (73.3%) showed premature 
bolus loss. Eight (26.7%) had intact oral transit time. 
Six (20.0%) exhibited intact swallowing reflex. Nine-
teen (63.3%) had vallecular residue. Twenty-six (86.7%) 
showed complete laryngeal elevation. Seventeen (56.7%) 
carried pyriform sinus residue. Twenty (66.7%) exhibited 
pharyngeal wall coating. Twenty-seven (90.0%) had an 
intact pharyngeal transit time. Thirteen (43.3%) showed 
aspiration. 
Comparison of these VDS subgroups revealed signifi-
cant differences in MPT among those assigned to groups 
based on bolus formation (7.3±4.9 vs 3.3±2.0; p=0.009), 
oral transit time (9.5±5.4 vs. 5.6±4.2; p=0.047), pharynge-
al swallow triggering (12.4±4.6 vs. 5.2±3.6; p<0.001), and 
laryngeal elevation (7.3±4.7 vs. 2.1±2.4; p=0.040) (Fig. 1).
Correlation of MPT with VDS, PAS, NIH-SSS scores 
A correlation analysis was conducted between the MPT 
and the dysphagia scales. Oral phase of VDS was defined 
as the sum of lip closure, bolus formation, mastication, 
apraxia, tongue-to-palate contact, premature bolus loss, 
and oral transit time. Pharyngeal phase of VDS was de-
fined as the sum of pharyngeal swallowing triggering, 
vallecular residue, laryngeal elevation, pyriform sinus 
residue, coating of the pharyngeal wall, and pharyngeal 
transit time. The MPT was moderately correlated with 
total score of VDS (r=-0.459, p=0.011), oral phase score 
Table 2. Comparison of VDS variables among subgroups 
VDS variable
PD
(n=10)
PS
(n=20)
Independent 
ambulation
(n=16)
Dependent 
ambulation
(n=14)
Normal 
MPT
(n=9)
Abnormal 
MPT
(n=21)
Total
(n=30)
Lip closure 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0
Bolus formation 0.6±1.3 0.5±1.1 0.4±1.0 0.6±1.3 0.0±0.0 0.7±1.3* 0.5±1.1
Mastication 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0
Apraxia 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0
Tongue to palate contact 0.5±1.6 0.0±0.0 0.0±0.0 0.4±1.3 0.0±0.0 0.2±1.1 0.2±0.9
Premature bolus loss 1.5±1.7 2.5±1.4 2.5±1.8 1.8±1.3 1.5±1.7 2.5±1.5 2.2±1.6
Oral transit time 2.4±1.3 2.1±1.4 2.3±1.3 2.1±1.4 1.7±1.6 2.4±1.2 2.2±1.3
PST 3.2±2.2 3.8±1.6 3.7±1.8 3.5±1.9 2.5±2.4 4.1±1.4 3.6±1.8
Vallecular residue 4.0±2.5 2.8±2.8 3.4±2.8 3.0±2.7 3.1±3.0 3.2±2.6 3.2±2.7
Laryngeal elevation 2.7±4.3 0.5±2.0 1.1±3.1 1.3±3.3 0.0±0.0 1.7±3.6* 1.2±3.1
Pyriform sinus residue 5.9±4.3 3.2±4.2 4.2±4.5 3.9±4.3 3.0±4.5 4.5±4.3 4.1±4.3
CPW 7.2±3.8 5.4±4.5 6.2±4.3 5.8±4.5 5.0±4.7 6.4±4.2 6. 0±4.3
Pharyngeal transit time 1.2±2.5 0.3±1.3 0.8±2.0 0.4±1.6 0.0±0.0 0.9±2.2 0.6±1.8
Aspiration 5.4±6.0 7.5±4.7 7.5±5.1 6.0±5.3 5.3±4.7 7.4±5.3 6.8±5.2
Total 34.5±24.1 28.5±13.7 31.9±17.9 28.9±17.9 22.1±14.3 34.1±18.0 30.5±17.7
Values are presented as mean±standard deviation. 
VDS, Videofluoroscopic Dysphagia Scale; PD, Parkinson’s disease; PS, Parkinsonian syndrome; MPT, maximal phona-
tion time; PST, pharyngeal swallow triggering; CPW, coating of pharyngeal wall.
*p<0.05.
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Fig. 2. Correlation of maximal phonation time (MPT) 
with oral phase score of VDS (A), pharyngeal phase score 
of VDS (B), and total score of VDS (C). VDS, Videofluoro-
scopic Dysphagia Scale.
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Fig. 1. Comparison of maximal 
phonation time (MPT) in the Vid-
eofluoroscopic Dysphagia Scale 
subgroups. *p<0.05 by indepen-
dent t-test.
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of VDS (r=-0.504, p=0.005), and pharyngeal phase score 
of VDS (r=-0.413, p=0.023) (Fig. 2). It also showed a weak 
correlation with the NIH-SSS (r=-0.361, p=0.050), but not 
the PAS (Fig. 3). 
DISCUSSION
In this study, bolus formation and the laryngeal eleva-
tion functions were significantly higher in the normal 
MPT group compared with the impaired group. When 
the VDS variable subgroups were also compared, those 
with intact bolus formation, oral transit time, pharyn-
geal swallow triggering, and laryngeal elevation showed 
significantly longer MPTs compared with the impaired 
groups, indicating an interactive correlation between 
swallowing and phonation.
In addition, the MPT correlated with oropharyngeal 
motor function, such as tongue movement (bolus forma-
tion, oral transit time), laryngeal elevation, and pharyn-
geal swallow triggering. This function may be attributed 
to an increased bolus volume with appropriate tongue 
movement when swallowing, leading to increased stimu-
lation of sensory receptors that trigger a pharyngeal swal-
lowing reflex [6,17].
VDS and NIH-SSS correlated with MPT in patients with 
PD and PS, which provides additional evidence that oro-
pharyngeal dysphagia correlates with phonatory dysfunc-
tion. There was no correlation between PAS and MPT, 
a weak correlation between NIH-SSS and MPT, and a 
moderate correlation between VDS and MPT. The PAS fo-
cuses on the presence of aspiration, whereas the NIH-SSS 
indicates remnant peristalsis, and other aspects of the 
pharyngeal phase. The VDS additionally indicates oral 
phase elements, showing comprehensive oropharyngeal 
dysfunction in patients suggesting that phonatory func-
tion is related to the quality of oropharyngeal swallowing 
function, but not directly to the aspiration itself. 
Swallowing is an organized sensorimotor process with-
in a complex neural network involving automatic and vo-
litional systems [18]. In patients with PD, dopaminergic 
drugs had no significant effect on non-motor symptoms 
[4] and other dysphagia treatments have therefore been 
attempted. Lee Silverman Voice Treatment (LSVT) re-
sulted in improved tongue movement during swallowing, 
and swallowing efficiency reduced oral residue and oral 
transit time [17]. Expiratory muscle strength training in 
patients with PD for 4 weeks also resulted in short-term 
improvement in PAS scores. The increase in duration 
and displacement of hyoid movement led to a wider and 
longer opening of the upper esophageal sphincter, im-
proving the coordination of airway protection and bolus 
flow through the oropharynx [18,19]. In another study, a 
significant improvement in the laryngeal elevation time 
was reported after 8 weeks of group therapeutic singing, 
which presumably protected the airway from foreign ma-
terial for a longer period [20].
These studies did not directly target swallowing. How-
ever, these types of training can recruit muscles that are 
involved in swallowing and stimulate similar central 
and peripheral neural control elements during training, 
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Fig. 3. Correlation of maximal phonation time (MPT) with PAS (A) and NIH-SSS scores (B). PAS, Penetration Aspira-
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and are therefore, considered to improve dysphagia [21]. 
Similarly, our study revealed several swallowing ele-
ments related to MPT. Since MPT is improved by training, 
voice therapy is a potential treatment for dysphagia. The 
aforementioned studies were typically conducted exclu-
sively in patients with idiopathic PD and with relatively 
mild H&Y stages. However, patients with PS and those 
at relatively advanced H&Y stage were also included in 
this study suggesting that a wider range of patients than 
previously demonstrated stand to benefit from voice 
therapy. PS is generally less responsive or not responsive 
to dopaminergic drug therapies than PD. Therefore, al-
ternative treatment methods are more important. 
In previous studies, MPT was used to indirectly evaluate 
laryngeal function and vocal fold vibration efficiencies. 
Instead of solely targeting MPT for training, MPT was 
included as a part of voice therapy, similar to LSVT, or in-
direct training using an expiratory muscle strength train-
ing program [10,11,17]. Since this study indicates that an 
increase in MPT leads to an improvement of swallowing 
symptoms, training that is designed and conducted to 
target MPT will directly confirm the treatment effects. 
In addition to MPT, diverse acoustic parameters such 
as intensity, jitter, shimmer, harmonics-to-noise ratio, 
voice onset time, sequential motion rate, and alternating 
motion rate can be measured to evaluate the voice. In 
this study, MPT was based on the subject’s characteris-
tics, ease of evaluation and parameter representation. In 
future studies, the relationship between different param-
eters and swallowing function needs to be investigated in 
a large group. 
Overall, there is a need for large-scale, well-designed, 
randomized, and controlled studies in order to correlate 
MPT with swallowing-related elements, as well as deter-
mine the short- and long-term effects of voice therapy 
on dysphagia, by comparing the results before and after 
treatment.
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